Dawn Christine Maroney Sells 30,000 Shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) President Dawn Christine Maroney sold 30,000 shares of the company’s stock in a transaction on Wednesday, January 15th. The shares were sold at an average price of $13.61, for a total value of $408,300.00. Following the completion of the transaction, the president now directly owns 1,606,097 shares in the company, valued at approximately $21,858,980.17. This represents a 1.83 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Dawn Christine Maroney also recently made the following trade(s):

• On Friday, November 15th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $11.35, for a total transaction of $340,500.00.

Alignment Healthcare Stock Performance

Alignment Healthcare stock opened at $14.58 on Friday. The company has a quick ratio of 1.60, a current ratio of 1.60 and a debt-to-equity ratio of 1.82. The stock has a market cap of $2.79 billion, a PE ratio of -18.94 and a beta of 1.45. Alignment Healthcare, Inc. has a 12-month low of $4.46 and a 12-month high of $14.79. The business’s 50-day moving average price is $11.94 and its two-hundred day moving average price is $10.78.

Alignment Healthcare (NASDAQ:ALHC) last released its quarterly earnings data on Tuesday, October 29th. The company reported ($0.14) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.14). The business had revenue of $692.43 million during the quarter, compared to analysts’ expectations of $662.11 million. Alignment Healthcare had a negative net margin of 5.84% and a negative return on equity of 108.69%. The firm’s quarterly revenue was up 51.6% compared to the same quarter last year. During the same period in the prior year, the company earned ($0.19) EPS. As a group, analysts expect that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of ALHC. nVerses Capital LLC bought a new stake in Alignment Healthcare during the 3rd quarter worth $95,000. Ballentine Partners LLC bought a new stake in shares of Alignment Healthcare during the fourth quarter worth about $121,000. Connor Clark & Lunn Investment Management Ltd. acquired a new position in shares of Alignment Healthcare in the third quarter valued at approximately $131,000. Creative Planning raised its holdings in Alignment Healthcare by 20.0% in the 3rd quarter. Creative Planning now owns 12,442 shares of the company’s stock valued at $147,000 after buying an additional 2,072 shares during the last quarter. Finally, Mackenzie Financial Corp boosted its position in Alignment Healthcare by 110.0% during the 2nd quarter. Mackenzie Financial Corp now owns 36,526 shares of the company’s stock worth $286,000 after buying an additional 19,129 shares during the period. 86.19% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of research firms have issued reports on ALHC. Barclays boosted their price objective on shares of Alignment Healthcare from $7.00 to $8.00 and gave the company an “underweight” rating in a report on Wednesday, October 30th. KeyCorp began coverage on Alignment Healthcare in a research report on Friday, October 11th. They set a “sector weight” rating on the stock. UBS Group raised their price objective on Alignment Healthcare from $9.00 to $12.00 and gave the stock a “neutral” rating in a research note on Wednesday, October 30th. Stifel Nicolaus upped their target price on Alignment Healthcare from $14.00 to $16.00 and gave the company a “buy” rating in a research report on Tuesday, January 14th. Finally, Stephens restated an “overweight” rating and issued a $17.00 price target on shares of Alignment Healthcare in a research report on Thursday, January 2nd. One analyst has rated the stock with a sell rating, two have given a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $11.88.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.